NEW YORK (GenomeWeb News) – Bruker said today that a member of the Laukien family sold two million of the company's shares in a block trade, and that CEO Frank Laukien bought 100,000 shares from the same family member in a private transaction.

The life science and environmental research tools maker, which now has a public float of 50.9 million shares, said that the unidentified Laukien family member is not involved in the company's business. The aggregate number of shares sold yesterday amounts to 12.6 percent of the selling shareholder's ownership.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.